| Janssen-Cilag AG - Veletri 1.5mg, Pulver zur Herstellung einer Infusionslösung |
| 62354 | | 02 | | Veletri 1.5mg | | Pulver zur Herstellung einer Infusionslösung | | B01AC09 | | Epoprostenol | | 07.08.2012 | | |
|
| Composition |
| Praeparatio cryodesiccata: epoprostenolum 1.5 mg ut epoprostenolum natricum, saccharum, argininum, natrii hydroxidum ad pH, pro vitro corresp. natrium 0.09 mg. |
| Packungsbestandteile |
| Praeparatio cryodesiccata: | | Lyophilisate | | | | | | Active Agent | Dose |
|---|
| Epoprostenol | 1.5 mg |
| | | | Inactive agents |
|---|
| Arginine | | Natrii Hydroxidum ad Ph | | Saccharum |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 002 | ampoule(s) | PR | PR | B | | Yes |
|
